PRO-DEX, INC. Notes Payable, Noncurrent
PRO-DEX, INC. (PDEX) had Notes Payable, Noncurrent of $13.27 million as of 2026-06-30, per its 10-K filed 2026-09-03.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2026-09-03
- 2026-06-30: Notes Payable, Noncurrent $13.27M.
- 2026-03-31: Notes Payable, Noncurrent $14.30M.
- 2025-12-31: Notes Payable, Noncurrent $8.01M.
- 2025-09-30: Notes Payable, Noncurrent $8.63M.
| Period end | Notes Payable, Noncurrent |
|---|---|
| 2026-06-30 | $13.27M 10-K · filed 2026-09-03 |
| 2026-03-31 | $14.30M 10-Q · filed 2026-04-30 |
| 2025-12-31 | $8.01M 10-Q · filed 2026-01-29 |
| 2025-09-30 | $8.63M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $9.25M 10-K · filed 2026-09-03 |
| 2025-03-31 | $9.86M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $10.47M 10-Q · filed 2025-01-30 |
| 2024-09-30 | $11.08M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $7.54M 10-Q · filed 2025-05-01 |
| 2018-03-31 | $15.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $31.00K 10-Q · filed 2018-02-08 |
| 2017-09-30 | $46.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $61.00K 10-Q · filed 2018-05-10 |
| 2017-03-31 | $76.00K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $91.00K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $105.00K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $46.00K 10-Q · filed 2017-05-11 |
| 2016-03-31 | $52.00K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $58.00K 10-Q · filed 2016-02-11 |
| 2015-09-30 | $65.00K 10-Q · filed 2015-11-10 |
| 2015-06-30 | $70.00K 10-K · filed 2016-09-15 |
| 2015-03-31 | $76.00K 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |